- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03132545
Resting Metabolic Rate, Fat Distribution, Endocrine and Metabolic Features in Polycystic Ovary Syndrome
April 24, 2017 updated by: Valeria Tagliaferri, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
In a longitudinal, prospective and observational study, patients with PCOS and controls wore the SenseWear Armband for 2 days.
Resting metabolic rati (kcal/die), total energy expenditure (MET, kcal) were evaluated.
Ultrasonographic pelvic examinations, hirsutism score, anthropometric and menstrual pattern evaluation, hormonal profile assays, oral glucose tolerance test (OGTT) and lipid profile were performed.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
160
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
group 1: women with PCOS diagnosed according with the Rotterdam Consensus Conference criteria group 2: healty women
Description
Inclusion Criteria:
- . PCOS diagnosed according with the Rotterdam Consensus Conference criteria
Exclusion Criteria:
- presence of a late-onset adrenal enzyme defect
- Significant liver or renal impairment
- pregnancy and nursing
- neoplasm
- cardiovascular disease
- other hormonal dysfunctions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
controls
|
Participants wore the SWA on their right arm
DEXA was used to estimate abdominal visceral adipose tissue and subcutaneous adipose tissue
|
|
PCOS
|
Participants wore the SWA on their right arm
DEXA was used to estimate abdominal visceral adipose tissue and subcutaneous adipose tissue
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
differences in resting metabolic rate
Time Frame: 2 days
|
2 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
differences in body fat distribution
Time Frame: 1 day
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2013
Primary Completion (Actual)
December 1, 2016
Study Completion (Actual)
March 1, 2017
Study Registration Dates
First Submitted
April 24, 2017
First Submitted That Met QC Criteria
April 24, 2017
First Posted (Actual)
April 28, 2017
Study Record Updates
Last Update Posted (Actual)
April 28, 2017
Last Update Submitted That Met QC Criteria
April 24, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ARMOC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Polycystic Ovary Syndrome
-
Universitair Ziekenhuis BrusselNot yet recruiting
-
University Hospital, Strasbourg, FranceRecruitingPolycystic Ovary Syndrome (PCOS)France
-
Mst.Sumyara KhatunRecruitingPolycystic Ovary Syndrome (PCOS)Bangladesh
-
Ege UniversityRecruitingPolycystic Ovary Syndrome (PCOS)Turkey (Türkiye)
-
Al-Azhar UniversityCompletedPCOS (Polycystic Ovary Syndrome)Egypt
-
Shanghai Zhongshan HospitalRecruiting
-
Federal State Budgetary Institution, V. A. Almazov...Not yet recruitingPCOS (Polycystic Ovary Syndrome)
-
The Cleveland ClinicAmerican Academy of Family PhysiciansRecruitingPCOS (Polycystic Ovary Syndrome)United States
-
Shanghai First Maternity and Infant HospitalGengma People's HospitalRecruitingPCOS (Polycystic Ovary Syndrome)China
-
Xuanwu Hospital, BeijingGuang'anmen Hospital of China Academy of Chinese Medical Sciences; Jinan Central... and other collaboratorsNot yet recruiting
Clinical Trials on SenseWear Armband (SWA) monitoring
-
University College of AntwerpUniversiteit AntwerpenCompletedCerebrovascular AccidentBelgium
-
Tel-Aviv Sourasky Medical CenterUnknownHungry-Satiation SituationIsrael
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
KU LeuvenCompletedSedentary LifestyleBelgium
-
Radboud University Medical CenterUnknownType 2 Diabetes Mellitus | Weight GainNetherlands
-
Catholic University of the Sacred HeartUnknown
-
Institut de Recherches Cliniques de MontrealCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
Novo Nordisk A/SBodyMediaCompletedDiabetes Type 2United States
-
Pennington Biomedical Research CenterCompleted